Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Calliditas Therapeutics AB publ (CALT) shares

Learn how to easily invest in Calliditas Therapeutics AB publ shares.

Calliditas Therapeutics AB publ is a biotechnology business based in the US. Calliditas Therapeutics AB publ stocks (CALT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $32.13 – a decrease of 14.54% over the previous week. Calliditas Therapeutics AB publ employs 65 staff and has a market cap (total outstanding stock value) of $570.3 million.

How to buy shares in Calliditas Therapeutics AB publ

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CALT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Calliditas Therapeutics AB publ stock price (NASDAQ:CALT)

Use our graph to track the performance of CALT stocks over time.

Calliditas Therapeutics AB publ shares at a glance

Information last updated 2022-01-23.
Latest market close$18.99
52-week range$14.22 - $33.19
50-day moving average $20.80
200-day moving average $25.15
Wall St. target price$63.20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Calliditas Therapeutics AB publ stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Calliditas Therapeutics AB publ price performance over time

Historical closes compared with the close of $18.99 from 2022-01-26

1 week (2022-01-21) -10.09%
1 month (2021-12-28) -24.04%
3 months (2021-10-28) -7.05%
6 months (2021-07-28) -35.63%
1 year (2021-01-28) -32.52%
2 years (2020-01-24) N/A
3 years (2019-01-24) N/A
5 years (2017-01-24) N/A

Calliditas Therapeutics AB publ financials

Gross profit TTM $874,000
Return on assets TTM -16.85%
Return on equity TTM -34.26%
Profit margin -224.05%
Book value N/A
Market capitalisation $570.3 million

TTM: trailing 12 months

Calliditas Therapeutics AB publ share dividends

We're not expecting Calliditas Therapeutics AB publ to pay a dividend over the next 12 months.

Calliditas Therapeutics AB publ share price volatility

Over the last 12 months, Calliditas Therapeutics AB publ's shares have ranged in value from as little as $14.22 up to $33.19. A popular way to gauge a stock's volatility is its "beta".

CALT.US volatility(beta: 1.45)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Calliditas Therapeutics AB publ's is 1.4517. This would suggest that Calliditas Therapeutics AB publ's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Calliditas Therapeutics AB publ overview

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. The company's lead product candidate is Nefecon, a oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site